Index of reports
> Cases with Infection in AN Immunocompromised Host (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace ES (Megestrol) where reactions include infection in an immunocompromised host. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Megace ES side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-22
Patient:
Reactions: Death, Endometritis, Unresponsive To Stimuli, Mental Status Changes, Immunodeficiency, Infection in AN Immunocompromised Host
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Megace ES
Dosage: 625 mg/ 5 ml, once daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-15
End date: 2012-06-06
Tramadol HCL
Dosage: 50 mg, tid
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Prilosec; Niferex; Colace; Lisinopril; Calcium Replacement
|